Compounds decrease polyQ toxicity in a <i>pqe-1</i> independent manner in aged animals. by Cindy Voisine (30589)

Reproductive transition paralleled a significant decrease in LDH5 and LDH1 expressions in nonTg hippocampus. by Fan Ding (302565)

“…<p>A. NonTg hippocampus demonstrated a an age-related decrease in LDH5 expression from 6 to 15 months of age, which was significant between 6 and 9, 9 and 12 months of age. …”

A significant decrease of paw swelling and radiographic damage in CFA-injected rats treated with CGS 21680 was detected. by Fabrizio Vincenzi (289325)

cAMP and PKA/AKAP1 decrease mobility and promote mitochondrial translocation of Drp1. by Ronald A. Merrill (224222)

AZD8055 treatment leads to a decrease in the percentage of CD4+ T cells and CD8+ T cells in vivo. by Shurong Hu (2634826)

Decreased membrane localization of myrGFP in <i>ACBD6</i>-deficient cells. by Eric Soupene (64584)

miR-135a decreases cell invasion by inhibiting ERRα expression. by Violaine Tribollet (237332)

Subjects:

Postsynaptic reduction of dTip60 in the nervous system leads to a decrease of synaptic boutons at larval NMJs. by Jessica Sarthi (199376)

METTL10 tri-methylates K318 in EF1A1. by Tadahiro Shimazu (619411)

Subjects:

Specific inhibition of host p38α MAPK leads to a minor decrease in epithelial cell invasion. by Françoise I. Bussière (692733)

Antiviral use is associated with a decrease in the rate of influenza-related complications, health care resource utilization, and costs by Chris Wallick (10131528)

List of selected metabolites that associate with diabetes at q-values <0.05 using log-scaled metabolite concentrations and assuming a linear model; %change is the increase or decrease of the mean in the diabetes group with respect to the control group; eta² is the proportion of the total variance that can be explained by the factor “diabetes” in the linear model; N is the number of valid data points that entered the analysis; the platform on which the corresponding metabolite was measured is indicated by the first letter of the provider: B = Biocrates, C = Chenomx, M = Metabolon. by Karsten Suhre (67967)

“…<p>List of selected metabolites that associate with diabetes at q-values <0.05 using log-scaled metabolite concentrations and assuming a linear model; %change is the increase or decrease of the mean in the diabetes group with respect to the control group; eta² is the proportion of the total variance that can be explained by the factor “diabetes” in the linear model; N is the number of valid data points that entered the analysis; the platform on which the corresponding metabolite was measured is indicated by the first letter of the provider: B = Biocrates, C = Chenomx, M = Metabolon.…”

Expression of Egln3 decreases tumor aggression, increases survival and normalizes glioma vascular architecture. by Vicki A. Sciorra (312082)

Decreased number of cilia in partially formed KV lumen. by Jeong-gyun Kim (4330168)

FLCN-deficiency leads to decreased Rho activity in sub-confluent cells and delays in wound closure. by Doug A. Medvetz (300145)

“…<b>B)</b> Rho activity was measured using a Rhotekin binding assay at 70% confluence. The FLCN-null UOK257 cells had a 2.5-fold decrease in active Rho levels (Rho GTP) compared to the FLCN re-expressing UOK257-2 cells (n = 3, p<0.05). …”

Expression of PON1 decreases superoxide levels in germ-free <i>D. melanogaster</i>. by Alejandro A. Pezzulo (138238)

Expression of HCMV US proteins by MSC decreases PBMNC proliferation and correlates with the levels of HLA-I. by Melisa A. Soland (162129)

Expression of human PON1 decreases superoxide levels in the gut of <i>D. melanogaster</i>. by Alejandro A. Pezzulo (138238)

Pharmacokinetic parameters of n-butylphthalide in rats (mean±SD, n = 10). by Xiangchen Li (512737)

Subjects:

Relation between the decrease in alpha (8–13 Hz) band power in Brodmann's area (BA) 10 in the rest trials and the decrease in theta (4–8 Hz) band power in BA 31 (A) in the rest trials, the decrease in beta (13–25 Hz) band power in BA 46 (B) in the rest trials, and the decrease in alpha (8–13 Hz) band power in BA 9 (C) in the rest trials. by Akira Ishii (437846)